{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:20:05Z","timestamp":1791267605142,"version":"4.1.0"},"reference-count":37,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,2,15]]},"abstract":"<jats:p>This study aimed to correlate the frequency of somatic mutations in the IgVH gene and the use of specific segments in the VH repertoire with the clinical and characteristic features of a series of 35 cases of splenic marginal zone lymphoma (SMZL). The cases were studied by seminested polymerase chain reaction by using primers from the FR1 and JH region. The results showed unexpected molecular heterogeneity in this entity, with 49% unmutated cases (less than 2% somatic mutations). The 7q31 deletions and a shorter overall survival were more frequent in this group. Additionally a high percentage (18 of 40 sequences) of SMZL cases showed usage of the VH1-2 segment, thereby emphasizing the singularity of this neoplasia, suggesting that this tumor derives from a highly selected B-cell population and encouraging the search for specific antigens that are pathogenically relevant in the genesis or progression of this tumor.<\/jats:p>","DOI":"10.1182\/blood.v99.4.1299","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:40Z","timestamp":1027774000000},"page":"1299-1304","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":138,"title":["Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course"],"prefix":"10.1182","volume":"99","author":[{"given":"Patricia","family":"Algara","sequence":"first","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol S.","family":"Mateo","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Sanchez-Beato","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mollejo","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculada C.","family":"Navas","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Romero","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Sole\u0301","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Salido","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Florensa","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mart\u0131\u0301nez","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[{"name":"From the Department of Genetics and Pathology, Virgen de la Salud Hospital, Toledo, Spain; the Centro Nacional de Investigaciones Oncologicas (CN10), Programa de Patologia Molecular, Madrid, Spain, the Laboratory of Citolog\u0131\u0301a Hematolo\u0301gica, Department of Pathology, Hospital del Mar, Barcelona, Spain; and the Department of Pathology, Hospital Clinic, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222580831200_B1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00000478-199707000-00005","article-title":"Lymph node involvement by splenic marginal zone lymphoma morphological an immunohistochemical features.","volume":"21","author":"Mollejo","year":"1997","journal-title":"Am J Pathol."},{"key":"2020021222580831200_B2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00125480-199705000-00051","article-title":"Splenic marginal zone lymphoma.","volume":"4","author":"Isaacson","year":"1997","journal-title":"Adv Anat Pathol."},{"key":"2020021222580831200_B3","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V84.11.3828.bloodjournal84113828","article-title":"The histopathology of splenic marginal lymphoma with villous lymphocytes.","volume":"84","author":"Isaacson","year":"1994","journal-title":"Blood."},{"key":"2020021222580831200_B4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2559.1996.d01-536.x","article-title":"Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma.","volume":"29","author":"Franco","year":"1996","journal-title":"Histopathology."},{"key":"2020021222580831200_B5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0046-8177(99)90031-X","article-title":"Splenic marginal zone lymphoma with increased number of blasts: an aggressive variant?","volume":"30","author":"Lloret","year":"1999","journal-title":"Hum Pathol."},{"key":"2020021222580831200_B6","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)65411-9","article-title":"7q31\u201332 allelic loss is a frequent finding in splenic marginal zone lymphoma.","volume":"154","author":"Mateo","year":"1999","journal-title":"Am J Pathol."},{"key":"2020021222580831200_B7","first-page":"71","article-title":"Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q.","volume":"86","author":"Sole","year":"2001","journal-title":"Haematologica."},{"key":"2020021222580831200_B8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.leu.2402073","article-title":"Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5\u2032 non-coding region of the bcl-6 gene.","volume":"15","author":"Mateo","year":"2001","journal-title":"Leukemia."},{"key":"2020021222580831200_B9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2559.1998.00478.x","article-title":"A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma.","volume":"33","author":"Piris","year":"1998","journal-title":"Histopathology."},{"key":"2020021222580831200_B10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00001622-200009000-00003","article-title":"Clinical relevance of immunoglobulin mutation analysis.","volume":"12","author":"Hummel","year":"2000","journal-title":"Curr Opin Oncol."},{"key":"2020021222580831200_B11","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1126\/science.280.5370.1750","article-title":"Mutations of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes.","volume":"280","author":"Shen","year":"1998","journal-title":"Science."},{"key":"2020021222580831200_B12","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1073\/pnas.95.20.11816","article-title":"BCL-6 mutations in normal germinal centre B cells: evidence of somatic hypermutation acting outside Ig loci.","volume":"95","author":"Pasqualucci","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021222580831200_B13","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90289-B","article-title":"Maturation of the immune response in germinal centres.","volume":"67","author":"Berek","year":"1991","journal-title":"Cell."},{"key":"2020021222580831200_B14","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1002\/j.1460-2075.1993.tb06189.x","article-title":"Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections.","volume":"12","author":"Ku\u0308ppers","year":"1993","journal-title":"EMBO J."},{"key":"2020021222580831200_B15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1084\/jem.180.1.329","article-title":"Analysis of somatic mutation in five B cell subsets of human tonsil.","volume":"180","author":"Pascual","year":"1994","journal-title":"J Exp Med."},{"key":"2020021222580831200_B16","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1182\/blood.V89.4.1288","article-title":"Evidence for a large compartment of IgM-expressing memory B cells in humans.","volume":"89","author":"Klein","year":"1997","journal-title":"Blood."},{"key":"2020021222580831200_B17","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas.","volume":"341","author":"Kuppers","year":"1999","journal-title":"N Engl J Med."},{"key":"2020021222580831200_B18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0167-5699(00)01650-9","article-title":"Molecular insights into the immunopathogenesis of follicular lymphoma.","volume":"21","author":"Stamatopoulos","year":"2000","journal-title":"Immunol Today."},{"key":"2020021222580831200_B19","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood.V95.5.1797.005k30_1797_1803","article-title":"Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas.","volume":"95","author":"Lossos","year":"2000","journal-title":"Blood."},{"key":"2020021222580831200_B20","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.4049\/jimmunol.155.5.2487","article-title":"Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity.","volume":"155","author":"Vescio","year":"1995","journal-title":"J Immunol."},{"key":"2020021222580831200_B21","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood.V85.8.2176.bloodjournal8582176","article-title":"Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity.","volume":"85","author":"Chapman","year":"1995","journal-title":"Blood."},{"key":"2020021222580831200_B22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V84.2.403.403","article-title":"Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle.","volume":"84","author":"Hummel","year":"1994","journal-title":"Blood."},{"key":"2020021222580831200_B23","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest."},{"key":"2020021222580831200_B24","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1182\/blood.V94.6.1837","article-title":"Mutational status of IgVH genes provides clinically valuable information in B-cell chronic lymphocytic leukemia.","volume":"94","author":"Naylor","year":"1999","journal-title":"Blood."},{"key":"2020021222580831200_B25","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated IgVH genes are associated with a more aggressive form of chronic lymphocytic leukemia.","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood."},{"key":"2020021222580831200_B26","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.","volume":"94","author":"Damle","year":"1999","journal-title":"Blood."},{"key":"2020021222580831200_B27","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V85.6.1603.bloodjournal8561603","article-title":"Splenic lymphoma with lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes.","volume":"85","author":"Zhu","year":"1995","journal-title":"Blood."},{"key":"2020021222580831200_B28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0046-8177(98)80007-5","article-title":"Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.","volume":"29","author":"Dunn-Walters","year":"1998","journal-title":"Human Pathol."},{"key":"2020021222580831200_B29","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood.V91.7.2381","article-title":"Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets.","volume":"91","author":"Tierens","year":"1998","journal-title":"Blood."},{"key":"2020021222580831200_B30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0046-8177(99)90010-2","article-title":"Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukaemia are composed of memory B lymphocytes.","volume":"30","author":"Miranda","year":"1999","journal-title":"Human Pathol."},{"key":"2020021222580831200_B31","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000478-199510000-00005","article-title":"Splenic marginal zone lymphoma, a distinctive type of low-grade B-cell lymphoma: a clinicopathological study of 13 cases.","volume":"19","author":"Mollejo","year":"1995","journal-title":"Am J Surg Pathol."},{"key":"2020021222580831200_B32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0167-5699(94)90175-9","article-title":"The CDR1 sequences of a major proportion of human germline IgVH genes are inherently susceptible to amino acid replacement.","volume":"15","author":"Chang","year":"1994","journal-title":"Immunol Today."},{"key":"2020021222580831200_B33","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.185.8.1435","article-title":"Lack of allelic exclusion in B cell chronic lymphocytic leukemia.","volume":"185","author":"Rassenti","year":"1997","journal-title":"J Exp Med."},{"key":"2020021222580831200_B34","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1172\/JCI119433","article-title":"Analysis of the human VH gene repertoire: differential effects of selection and somatic hypermutation on human peripheral CD5(+)\/IgM+ and CD5(\u2212)\/IgM+ B cells.","volume":"99","author":"Brezinschek","year":"1997","journal-title":"J Clin Invest."},{"key":"2020021222580831200_B35","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1182\/blood.V95.12.3878","article-title":"Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1\u201369 with distinctive CDR3 features.","volume":"95","author":"Miklos","year":"2000","journal-title":"Blood."},{"key":"2020021222580831200_B36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V97.4.1023","article-title":"V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen.","volume":"97","author":"Chan","year":"2000","journal-title":"Blood."},{"key":"2020021222580831200_B37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1365-2141.1999.01732.x","article-title":"The genetic variability of the VH genes in follicular lymphoma: the impact of the hypermutation mechanism.","volume":"107","author":"Noppe","year":"1999","journal-title":"Br J Haematol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/4\/1299\/1681194\/h8040201299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/4\/1299\/1681194\/h8040201299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T06:42:09Z","timestamp":1704523329000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/4\/1299\/110056\/Analysis-of-the-IgVH-somatic-mutations-in-splenic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,15]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.4.1299","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2,15]]}}}